No Data
No Data
Top 10 U.S. Stocks With 3-month Earnings Momentum as Net Upgrades Brighten: Berenberg
Health Care Up After Bristol-Myers Earnings -- Health Care Roundup
Truist Financial Maintains Bristol-Myers Squibb(BMY.US) With Buy Rating, Announces Target Price $62
Bristol-Myers Squibb Options Spot-On: On July 26th, 169.83K Contracts Were Traded, With 876.21K Open Interest
Tech Stocks Slide On Earnings, US Economy Flexes Muscles, Small-Cap Rally Continues: This Week In The Markets
Sector Update: Health Care Stocks Higher Late Afternoon
No Data
SuperNoobPaPa : I think you sold a good stock which was acquired at very good price. Even the price gone up today, it is just a reflection of potential strong share price recovery. The sold down was mainly due to concern on company’s recent acquisition. Be that as it may, it’s worth to hold a 5% dividend yield company while BMY derives synergy from their recent acquisition. And if the company can deliver, share price will normalized and the upside could be 40% of your acquired price.
Ginvest SuperNoobPaPa : I agree with you. Patience is the game, I have an open order to sell at 60, and collect the dividend along the way
thoughtful Bat_8163 SuperNoobPaPa : Totally agreed. It is a long term play
Wealth Accumulator : Yes. Agree with Supernoobpapa